Kardigan (KARD) vs Nanobiotix S.A. (NBTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Kardigan is the larger company by market cap ($1.29 billion vs $1.25 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KARD | NBTX |
|---|---|---|
| Share price | $13.83 | $24.62 |
| Market cap | $1.29B | $1.25B |
| 1-day change | +2.52% | -2.42% |
| 5-year return | — | +92.04% |
| EPS (TTM) | $-10.65 | $-1.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $27.00 | $57.14 |
| 52-week low | $12.32 | $14.78 |
| Distance from 52-week high | -48.78% | -56.91% |
| Average volume | 477.59K | 147.71K |
| Shares outstanding | 93.50M | 50.92M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
KARD vs NBTX FAQ
Which is bigger, Kardigan or Nanobiotix S.A.?
Kardigan (KARD) is larger, with a market capitalization of $1.29B compared with $1.25B for Nanobiotix S.A. (NBTX).
Are Kardigan and Nanobiotix S.A. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.